EX-23.1 2 sum-ex231_20211231x10xkaxu.htm EX-23.1
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-249316 and 333-251958) and Form S-8 (Nos. 333-249313, 333-238582, and 333-264163) of Summit Therapeutics Inc. of our report dated March 17, 2022 relating to the financial statements, which appears in this Form 10-K/A.
/s/ PricewaterhouseCoopers LLP
Boston, MA
December 21, 2022